ELAPRASE is a prescription medicine for patients with Hunter syndrome. If you have question, please e-mail Allevaire Indian Team or call Allevaire Network on +91-9818274099 (Mr. Kamal Kaushal) for further details.
ELAPRASE (idursulfase) is an IV infusion used to treat some of the symptoms of a genetic condition called Hunter’s syndrome, also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis). Idursulfase contains a natural enzyme that some people lack because of a genetic disorder. Elaprase helps replace this missing enzyme.
ELAPRASE is a prescription medicine for patients with Hunter syndrome
ELAPRASE has been shown to improve walking ability in patients 5 yrs and older.
In patients 16 months to 5 yrs old, ELAPRASE did not show improvement in disease-related symptoms or long term clinical result; however, treatment with ELAPRASE has reduced spleen size similarly to patients 5 yrs and older.
It is not known if ELAPRASE is safe and effective in children under 16 months old.
ELAPRASE (idursulfase) Injection suppliers in India. Allevaire India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
The order for ELAPRASE (idursulfase) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
ELAPRASE is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).
ELAPRASE has been shown to improve walking capacity in patients 5 years and older.
In patients 16 months to 5 years of age, no data are available to demonstrate improvement in disease-related symptoms or long term clinical outcome; however, treatment with ELAPRASE has reduced spleen volume similarly to that of adults and children 5 years of age and older.
Medicine Name: ELAPRASE Injection
Generic Name: idursulfase
Approval Date: July 24, 2006
Company Name: Shire Pharmaceuticals.
Injection: 6 mg/3 mL (2 mg/mL) in single-use vial
ELAPRASE (idursulfase) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ELAPRASE (idursulfase) Injection on prescription and Import License in Patient’s Name only.
For foreign countries patients, ELAPRASE (idursulfase) Injection can be made available in Send your inquiry to find ELAPRASE (idursulfase) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For ELAPRASE (idursulfase) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details